The University of Chicago Header Logo

Connection

Mary Rinella to Sulfoxides

Back to Details
This is a "connection" page, showing publications Mary Rinella has written about Sulfoxides.
Mary Rinella
Connection Strength
0.182
Sulfoxides
  1. A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trial. Contemp Clin Trials. 2020 01; 88:105889.
    View in: PubMed
    Score: 0.182
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.